Product Code: ETC12322457 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Hospital Acquired Urinary Tract Infection Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Hospital Acquired Urinary Tract Infection Market - Industry Life Cycle |
3.4 Mexico Hospital Acquired Urinary Tract Infection Market - Porter's Five Forces |
3.5 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Infection Type, 2021 & 2031F |
3.6 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Diagnostic Method, 2021 & 2031F |
3.7 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Hospital Acquired Urinary Tract Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hospital-acquired urinary tract infections in Mexico due to factors such as aging population, prolonged hospital stays, and antibiotic resistance. |
4.2.2 Growing awareness and focus on infection control practices and protocols in Mexican hospitals. |
4.2.3 Technological advancements in diagnostic tools and treatment options for urinary tract infections in hospital settings. |
4.3 Market Restraints |
4.3.1 Lack of standardized infection control practices across all hospitals in Mexico. |
4.3.2 Limited access to proper sanitation facilities and resources in some healthcare institutions. |
4.3.3 Budget constraints and resource limitations in implementing infection prevention measures in hospitals. |
5 Mexico Hospital Acquired Urinary Tract Infection Market Trends |
6 Mexico Hospital Acquired Urinary Tract Infection Market, By Types |
6.1 Mexico Hospital Acquired Urinary Tract Infection Market, By Infection Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Infection Type, 2021 - 2031F |
6.1.3 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Catheter-associated UTI, 2021 - 2031F |
6.1.4 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Drug-resistant UTI, 2021 - 2031F |
6.1.5 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Recurrent UTI, 2021 - 2031F |
6.1.6 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Asymptomatic Bacteriuria, 2021 - 2031F |
6.2 Mexico Hospital Acquired Urinary Tract Infection Market, By Diagnostic Method |
6.2.1 Overview and Analysis |
6.2.2 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Urine Culture, 2021 - 2031F |
6.2.3 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By PCR-based Testing, 2021 - 2031F |
6.2.4 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Microscopy, 2021 - 2031F |
6.2.5 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Rapid Dipstick Tests, 2021 - 2031F |
6.3 Mexico Hospital Acquired Urinary Tract Infection Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Long-term Care Patients, 2021 - 2031F |
6.3.3 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Hospitalized Patients, 2021 - 2031F |
6.3.4 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Elderly Patients, 2021 - 2031F |
6.3.5 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Outpatient Clinics, 2021 - 2031F |
6.4 Mexico Hospital Acquired Urinary Tract Infection Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Infection Monitoring, 2021 - 2031F |
6.4.3 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Antibiotic Resistance Detection, 2021 - 2031F |
6.4.4 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Chronic Infection Management, 2021 - 2031F |
6.4.5 Mexico Hospital Acquired Urinary Tract Infection Market Revenues & Volume, By Early Detection, 2021 - 2031F |
7 Mexico Hospital Acquired Urinary Tract Infection Market Import-Export Trade Statistics |
7.1 Mexico Hospital Acquired Urinary Tract Infection Market Export to Major Countries |
7.2 Mexico Hospital Acquired Urinary Tract Infection Market Imports from Major Countries |
8 Mexico Hospital Acquired Urinary Tract Infection Market Key Performance Indicators |
8.1 Rate of compliance with infection control protocols in Mexican hospitals. |
8.2 Number of reported cases of hospital-acquired urinary tract infections in Mexico. |
8.3 Adoption rate of advanced diagnostic tools for early detection of urinary tract infections in hospital settings. |
9 Mexico Hospital Acquired Urinary Tract Infection Market - Opportunity Assessment |
9.1 Mexico Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Infection Type, 2021 & 2031F |
9.2 Mexico Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Diagnostic Method, 2021 & 2031F |
9.3 Mexico Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mexico Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Hospital Acquired Urinary Tract Infection Market - Competitive Landscape |
10.1 Mexico Hospital Acquired Urinary Tract Infection Market Revenue Share, By Companies, 2024 |
10.2 Mexico Hospital Acquired Urinary Tract Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |